PROFERDEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Proferdex, and when can generic versions of Proferdex launch?
Proferdex is a drug marketed by New River and is included in one NDA.
The generic ingredient in PROFERDEX is ferric oxyhydroxide. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ferric oxyhydroxide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROFERDEX?
- What are the global sales for PROFERDEX?
- What is Average Wholesale Price for PROFERDEX?
Summary for PROFERDEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
DailyMed Link: | PROFERDEX at DailyMed |
![PROFERDEX drug patent expirations Drug patent expirations by year for PROFERDEX](/p/graph/s/t/PROFERDEX-patent-expirations.png)
US Patents and Regulatory Information for PROFERDEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
New River | PROFERDEX | ferric oxyhydroxide | INJECTABLE;INJECTION | 017807-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |